首页> 美国卫生研究院文献>Current Controlled Trials in Cardiovascular Medicine >Structured proactive care coordination versus usual care for Improving Morbidity during Post-Acute Care Transitions for Sepsis (IMPACTS): a pragmatic randomized controlled trial
【2h】

Structured proactive care coordination versus usual care for Improving Morbidity during Post-Acute Care Transitions for Sepsis (IMPACTS): a pragmatic randomized controlled trial

机译:在脓毒症急性护理后过渡期间改善发病率的结构化主动式护理协调与常规护理:一项实用随机对照试验

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Patient flow diagram for participation in THE IMPACTS trial. The study population includes adults presenting to the Emergency Department (ED) who meet the following inclusion criteria: ≥ 18 years of age; oral or parenteral antibiotic or bacterial culture order within 24 h of ED presentation and either culture drawn first, antibiotics ordered within 48 h or antibiotics ordered first, culture ordered within 48 h; not discharged from the hospital at the time the daily list of eligible patients is generated each weekday morning; and deemed high risk for either 30-day readmission or mortality using risk-scoring models applied daily to real-time clinical data on acute and chronic factors. Patients are excluded based on receipt of prophylactic antibiotics only, hospital transfers, “do not resuscitate” or “do not intubate” (DNR/DNI) code status, distance of residence from treating hospital, and prior study randomization. Patients who have infection ruled out prior to hospital discharge are also excluded. Improving Morbidity during Post-Acute Care Transitions for Sepsis, Sepsis Transition and Recovery
机译:参与THE IMPACTS试验的患者流程图。研究人群包括符合以下入选标准的急诊成年人(ED):≥18岁。 ED出现后24小时内口服或肠胃外抗生素或细菌培养命令,首先进行培养,在48h内命令抗生素,或首先在48h内命令细菌培养;在每个工作日早晨生成符合条件的患者的每日清单时尚未出院;并使用每天应用于急性和慢性因素实时临床数据的风险评分模型,将其视为30天再入院或死亡的高风险。仅根据预防性抗生素的接受,医院转移,“请勿复苏”或“请勿插管”(DNR / DNI)代码状态,离治疗医院的居住距离以及先前的研究随机分组将患者排除在外。排除了出院前已被感染的患者。在脓毒症,脓毒症转移和恢复的急性护理后过渡期间改善发病率

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号